Giovannoni G, et al. Cladribine tablets in high disease activity (HDA) subgroups from the CLARITY study of patients with relapsing multiple sclerosis (RMS). EP1157. EAN 2017.
Prevalentie en risicofactoren van juveniele myoclonus epilepsie
nov 2018 | Epilepsie